Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.

Authors :: Godfrey J
Querfeld C
Song J
Source :: The New England journal of medicine [N Engl J Med] 2024 Sep 05; Vol. 391 (9), pp. 869-870.
Publication Year :: 2024

Subjects :: Humans
Biological Products administration & dosage
Biological Products adverse effects
Cytokine Release Syndrome immunology
Herpesvirus 4, Human isolation & purification
Receptors, Chimeric Antigen immunology
Risk
Antineoplastic Agents, Immunological administration & dosage
Antineoplastic Agents, Immunological adverse effects
Immunotherapy, Adoptive adverse effects
Immunotherapy, Adoptive methods
Lymphoma, B-Cell immunology
Lymphoma, B-Cell therapy
Lymphoma, B-Cell virology
Lymphoma, T-Cell diagnosis
Lymphoma, T-Cell immunology
Neoplasms, Second Primary diagnosis
Neoplasms, Second Primary immunology

Full Text Access

Tools